MKSI insider sale notice — 300 vested shares to be sold via Fidelity
Rhea-AI Filing Summary
Form 144 notice filed for MKSI insider sale. The filer plans to sell 300 shares of common stock through Fidelity Brokerage Services on NASDAQ with an aggregate market value of $36,642 and an approximate sale date of 10/01/2025. The 300 shares were acquired on 05/06/2024 through restricted stock vesting as compensation and were paid for on 05/06/2024. The filing also discloses a sale by Jacqueline Moloney of 300 shares on 08/01/2025 for gross proceeds of $27,630. By signing, the seller represents they are not aware of any undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small insider sale of vested restricted shares; transaction appears routine and not materially informative.
The filing documents a planned sale of 300 common shares valued at $36,642 and notes a prior sale of 300 shares for $27,630. The shares were acquired via restricted stock vesting on 05/06/2024 and paid as compensation, indicating these were employee-held, routine equity realizations rather than open-market dispositions after large holdings or transfers. The use of a broker (Fidelity) and the seller's attestation that no material nonpublic information exists align with standard compliance procedures for Rule 144 notices. Given the small size, this transaction is unlikely to move market perception or valuation materially.
TL;DR: Governance controls appear followed; disclosure and attestation are standard for Rule 144 sales.
The notice includes required details: acquisition method (restricted stock vesting), acquisition and payment dates, broker information, planned sale timing, and past three-month sale. The seller's signature representation about material nonpublic information and reference to Rule 10b5-1 compliance language reflect adherence to insider-trading controls. No departures from expected governance or procedural concerns are evident from the provided content.